Main Article Content
Nowadays, due to the rapid increase in the number of stress factors, it is especially important to use psychotherapy and psychopharmacotherapy in the combination treatment of patients with diseases of the gastrointestinal tract. Psychogenic overlaying plays a leading role in the clinical picture of the disease and determines the decreased performance in patients. Objective. To evaluate the effectiveness of therapy with psychocorrective agents in patients with gastroesophageal reflux disease (GERD) associated with dysfunction of the biliary system, if they have depressive and anxiety symptoms. Materials and methods. All patients were divided into 2 groups: group I consisted of 27 patients, who received only basic combination treatment, group II — of 25 patients, who in addition to the basic treatment received thioridazine, which is a piperidine derivative of phenothiazine and belongs to the group of neuroleptics. Both groups were representative by the age, duration and course of the disease. All patients demonstrate anxiety and depressive symptoms on the HADS scale. Questionnaire SF‑36 was used to analyze the quality of life. Treatment efficacy was assessed 14 days after. Results. As a result of the treatment, an improvement in overall well-being was observed in both groups against the background of reduction in the pain and dyspeptic syndromes. Additional prescription of psychocorrectives (thioridazine) to the basic therapy results in greater positive changes in the intensity of anxiety and depressive symptoms. The distribution of patients by the level of anxiety and depression after treatment showed that these indicators were absent more often in group II (by 2.6 and 1.5 times, respectively). However, cases of clinically significant anxiety and depression were 4.6 and 3.7 times more often in patients, who did not receive thioridazine. The difference in points between the level of anxiety and depression before and after the treatment was 4 times higher in patients, who additionally received psychocorrection. Also, comparing scores before and after the treatment, we have found significant improvement in the quality of life in group II. Conclusion. The inclusion of thioridazine into the basic therapy in the presence of depressive and anxiety disorders in patients with GERD associated with dysfunction of the biliary system improves the clinical effectiveness of pharmacotherapy of this comorbid pathology.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Nojkov B. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2008, no. 27, pp. 473-482.
Odintsova V.V. Features of emotional sphere of patients gastroenterological profile. Vestnik St. Petersburg State University, 2012, vol. 12, no. 9, pp. 36-39. (In Russ.).
Mizyed I., Fass S.S., Fass R. Review article: gastro-oesophageal reflux disease and psychological comorbidity. Aliment. Pharmacol. Ther, 2009, no. 29, pp. 351-358.
Sidorov P.I. Novikov I.A. Psychosomatic diseases: concept, prevalence, quality of life, medical and social assistance to patients. [electronic resource] Medical psychology in Russia: the electron. scientific. zh. 2010; 1. URL: http: // medpsy.ru (reference date: 30.08.2016). (In Russ.).
Plotnikov E.Y., Seledtsov A.M., Shamrai M.A. Psychosomatic aspects of gastroenterology. Therapist, 2012, no. 10, pp. 44–49. (In Russ.).
Zimmerman Y.S. Gastroenterologiya. depressivniy syndrome v gastroenterologii [Gastroenterology. Depressive syndrome in gastroenterology]. Moscow, GEOTAR-Media, 2012, 799 p.
Kosinskaya S.V. Objectification of anxiety and depressive disorders and rationale destination of their correction in patients with gastrointestinal profile. Gastroenterology: zbіrnik of naukova articles, no. 4(50), pp. 13-17. (In Ukraine).
Abilov K.U. Clinical features of psychogenic disorders in patients with gastroesophageal reflux disease. Neurosurgery and neurology of Kazakhstan, 2010, no. 2, 3 (15, 16), pp. 182-183. (In Kazakhstan)
Zigmond A.S., Snaith R.P. HADS Scale. Available at: http://paracels55.ru/_ld/0/2_HADS_SR_Scale.pdf (accessed 05.09.2015).
Ware J.E. The SF-36 Health Survey. Available at: http://www.rand.org/health/surveys_tools/mos/36-item-short-form/survey-instrument.html (accessed 15.08.2015).
Cheganov A.V. Shevchenko V.V. Experience with the drug Polisorb MP in patients with viral liver cirrhosis. Doctor, 2010, no. 2, pp. 54-56.